|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 29, 2017 ) The Latin America market for nuclear medicine Radiopharmaceuticals Market is estimated at $585 Million in 2015 and is poised to reach $1.05 billion by 2020, growing at a CAGR of 12.4%. Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.
View Full Report @ http://www.marketdataforecast.com/market-reports/latin-america-nuclear-medicine-radiopharmaceuticals-market-133/
Increasing incidence of cancer and cardiac ailments, immense technological advancements, increasing demand for SPECT and PET applications along with the growing public awareness for healthcare are fuelling the market growth for Radiopharmaceuticals. Further, Integration of X ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a major driving factor for the growth of the market. Strict regulatory frameworks pose a major hurdle to the translational research and clinical investigations. Reimbursement issues are other major issues blocking the growth of the market. In addition, shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also restraining the Latin America nuclear medicine Radioisotopes market.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/latin-america-nuclear-medicine-radiopharmaceuticals-market-133/request-sample
The market of radiopharmaceuticals is segmented into Diagnostic radioisotopes and Therapeutic radioisotopes. Diagnostic radioisotope market is further sub segmented into SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine) and PET (Fluorine-18, Rubidium-82) radioisotopes. Therapeutic radioisotopes cover Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177), Alpha Emitters (Radium-223) and Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192). By application market is segmented into (cardiology, lymphoma, thyroid, neurology oncology, and others). Furthermore, on the basis of geography, the Latin America Market is segmented into four regions namely, Argentina, Brazil, Chile and Mexico.
Avail Discount @ http://www.marketdataforecast.com/market-reports/latin-america-nuclear-medicine-radiopharmaceuticals-market-133/request-discount
Radiopharmaceuticals market is the dominating segment and estimated to account for 90 % of the market while therapeutic radioisotopes contribute for 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18, Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future growth of PET radioisotopes market.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/latin-america-nuclear-medicine-radiopharmaceuticals-market-133
Some of the key players influencing the Latin America nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
